Rick E Winningham insider trades

Open-market stock purchases and sales by Rick E Winningham, CHIEF EXECUTIVE OFFICER at Theravance Biopharma, Inc, from SEC Form 4 filings since Feb 10, 2010.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$5.3M
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$408K
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$3.4K
Aug 20, 2026TBPH Theravance Biopharma, IncSold (not open market)$340K
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
May 22, 2026JAZZ Jazz Pharmaceuticals plcSold$662K
May 22, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
May 20, 2026TBPH Theravance Biopharma, IncSold (not open market)$332K
Apr 1, 2026TBPH Theravance Biopharma, IncBought (not open market)—
Feb 20, 2026TBPH Theravance Biopharma, IncSold (not open market)$1.5M
Nov 20, 2025TBPH Theravance Biopharma, IncSold (not open market)$1M
Nov 19, 2025TBPH Theravance Biopharma, IncBought (not open market)—
Nov 18, 2025JAZZ Jazz Pharmaceuticals plcSold$995K

Companies traded

  • TBPH Theravance Biopharma, Inc: 3 buys, 1 sale, last Sep 23, 2026
  • JAZZ Jazz Pharmaceuticals plc: 20 sales, last Aug 31, 2026
  • OMED OncoMed Pharmaceuticals Inc: other filings, last Jun 22, 2018
  • THRX Theravance Inc: 16 sales, last Aug 15, 2014

Get free alerts when Rick E Winningham files a new trade →